Similarly, our results show that sesamin can disrupt cell cycle progression and inhibit the proliferation of human HeLa and SiHa cervical cancer cells by inducing p53 activation, which indicate that sesamin may have potential anticancer activity against human cervical cancer. This evidence concerns the gene TP53 and cervical carcinoma.